R&D Systems™ Recombinant Mouse VEGFR3/Flt-4 Fc Chimera Protein

Catalog No.
743R3100	100ug; Carrier Free

Catalog No. 743R3100 Supplier R&D Systems™ Supplier No. 743R3100

Description

Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity

The Recombinant Mouse VEGFR3/Flt-4 Fc Chimera Protein is derived from Sf 21 (baculovirus). The Recombinant Mouse VEGFR3/Flt-4 Fc Chimera Protein has been validated for the following applications: Binding Activity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 14257
• Molecular Weight (g/mol): Predicted MW: 112kDa (monomer) Observed MW: 123kDa with two additional minor bands at 73kDa and 60kDa, reducing conditions
• Name: VEGFR3/Flt-4
• Quantity: 100μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived mouse VEGFR3/Flt-4 protein, (N-terminus) Met Mouse VEGFR3 (Tyr25-Asp770) Accession &Num; P35917 IEGRDID Human IgG1 (Pro100-Lys330) 6-His tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.1 EU per 1μg of the protein by the LAL method.
• Gene Alias: EC 2.7.10, EC 2.7.10.1, FLT4, FLT-4, fms-related tyrosine kinase 4, LMPH1A, PCLFLT41, soluble VEGFR3 variant 1, soluble VEGFR3 variant 2, soluble VEGFR3 variant 3, Tyrosine-protein kinase receptor FLT4, vascular endothelial growth factor receptor 3, VEGF R3, VEGFR-3, VEGFR3Fms-like tyrosine kinase 4
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Purity or Quality Grade: 95%, by SDS-PAGE under reducing conditions and visualized by silver stain.